The Universal Code of Aging: How a Nature Study Mapping 11,000 Gene Profiles Is Rewriting Longevity Science

A landmark Nature study from Mass General Brigham analyzed 11,000 gene expression profiles across four mammalian species and found that aging leaves the same molecular fingerprint in virtually every tissue and cell type. The implications for measuring and modifying biological age have never been clearer.

Presented By Our Partners

For decades, aging researchers faced a fundamental paradox: every organ in the human body ages, yet each seemed to age in its own way. Liver cells, immune cells, neurons, and muscle fibers all lose function over time, but the molecular rules governing that decline appeared unique to each tissue type. That assumption has now been overturned.

A team led by investigators at Mass General Brigham has published a study in Nature revealing that the molecular signature of aging is remarkably conserved across tissues, cell types, and even mammalian species. Drawing on more than 11,000 gene expression profiles from over 25 tissues in four mammals, including mice, rats, macaques, and humans, the researchers identified a shared code that predicts not just chronological age but mortality risk itself. The paper, “Universal transcriptomic hallmarks of mammalian ageing and mortality,” was published May 27, 2026, with DOI: 10.1038/s41586-026-10542-3.

The finding represents one of the most comprehensive molecular portraits of aging ever assembled, and it has immediate implications for how clinicians might one day measure biological age, predict disease risk, and evaluate whether interventions, from calorie restriction to emerging longevity drugs, are actually working at the cellular level.

The Problem With Measuring Biological Age

Aging science has long been bedeviled by the gap between chronological age and biological age. Two sixty-year-olds can look, feel, and function decades apart from each other. Chronological age, the number of years since birth, tells a physician almost nothing about the pace at which an individual’s cells are deteriorating. Biological age is what actually matters for health outcomes, but measuring it has proven remarkably difficult.

Prior efforts produced tools called biological clocks, the most prominent being epigenetic clocks that measure DNA methylation patterns. Steve Horvath’s pioneering work at UCLA introduced the concept that the chemical modifications layered onto DNA could serve as a molecular timer, correlating strongly with age. Those clocks have been valuable, but they have limitations. Methylation patterns are static snapshots and do not always reflect the dynamic molecular processes driving cellular decline. They also do not easily reveal which biological pathways are accelerating or decelerating age.

The new Mass General Brigham approach takes a different route. Instead of measuring chemical modifications to DNA, it measures gene expression, which genes are actively turned on or off, and at what levels, across the full tissue landscape of aging organisms. This transcriptomic approach captures the living, moment-to-moment state of cellular biology rather than the more static methylation record.

The Scale of the Study and What the Researchers Found

Lead author Alexander Tyshkovskiy, PhD, an investigator in the Division of Genetics at Mass General Brigham, and senior author Vadim N. Gladyshev, PhD, a geneticist in the same division, assembled a dataset of extraordinary depth. Their team, which included collaborators at Tohoku University in Japan and institutions across North America and Europe, integrated 11,000-plus transcriptomes spanning more than 25 tissue types across mice, rats, macaques, and humans.

The central question was whether aging, despite its apparent tissue-by-tissue variation, leaves behind a universal molecular fingerprint. The answer, published across multiple analyses in the Nature paper, is a decisive yes.

“We found that most cell types share these conserved molecular changes with age, despite having very different origins and functions: from immune cells and stem cells to liver cells and muscle cells,” Tyshkovskiy said in the institutional press release from Mass General Brigham. “The same biomarkers were also predictive of time to death in humans and responsive to chronic diseases and lifespan-modulating interventions, such as calorie restriction, in mice.”

That last phrase deserves emphasis. The same gene expression patterns that track aging in a mouse liver also tracked aging in a human immune cell. And those same patterns responded to calorie restriction, one of the most reliably lifespan-extending interventions in animal research. This suggests that the molecular code the team uncovered is not merely a readout of aging: it is a readout of the biological processes that drive aging forward or hold them back.

The 28 Modules: Aging Is Not One Process, It Is Many

One of the most scientifically significant contributions of the study is its decomposition of the aging signal into discrete biological modules. Using a method called weighted gene co-expression network analysis, or WGCNA, the team identified 28 robust gene co-expression modules, each representing a distinct biological process linked to the aging trajectory.

Among the key processes captured in those modules: inflammation, energy production and mitochondrial function, extracellular matrix organization, DNA repair and genome stability, and immune regulation. This matters enormously for therapeutic development. It means aging is not a single unified phenomenon that must be addressed all at once. It is a collection of coordinated molecular processes, and each module represents a distinct potential intervention target.

Featured Partner

Invest in the Infrastructure Behind Modern Medicine

As healthcare expands beyond hospital walls, the buildings and campuses supporting that shift are generating compelling returns for investors who move early. The Healthcare Real Estate Fund offers qualified investors direct access to a curated portfolio of medical office, outpatient, and specialty care facilities.

Learn More →

The team built individual transcriptomic clocks for each of the 28 modules, using elastic net regression to predict both chronological age and expected mortality with varying precision depending on the module. This created a toolkit that does not just answer “how old are you biologically?” but “which specific aging processes are accelerating in your biology right now?”

“These aging clocks represent a potential new way to measure aging in greater detail and could help predict disease and mortality risk, characterize treatment effects, and personalize care based on biological age,” said Gladyshev. “Future therapies could target both specific aging-related processes, like inflammation or metabolism, and aging as a whole.”

Two Biomarkers That Cross the Species Barrier

Among the specific molecular signatures identified, two proteins stand out for their immediate translational relevance: CDKN1A and LGALS3.

CDKN1A, also known as p21, is a protein that regulates the cell cycle. It is already well-studied as a marker of cellular senescence, the state in which cells stop dividing and begin secreting pro-inflammatory signals. The finding that CDKN1A is a universal transcriptomic hallmark of aging across mammalian tissues adds significant weight to the hypothesis that cellular senescence is a central, not peripheral, driver of systemic aging. This reinforces the biological rationale behind the emerging field of senolytics, drugs designed to selectively clear senescent cells from tissues.

LGALS3 encodes galectin-3, a lectin protein that plays roles in inflammation, immune modulation, and fibrosis. Elevated galectin-3 has been linked in previous research to heart failure, fibrosis, and inflammatory disease. The confirmation here that its gene expression patterns correlate universally with aging and mortality, validated against the UK Biobank, one of the largest population health databases in the world, marks it as a serious candidate for therapeutic targeting and clinical biomarker development.

Both proteins had their expression levels associated with mortality and multimorbidity in UK Biobank data, lending the findings direct human relevance beyond the animal model work. The UK Biobank validation is significant: it means the universal aging signatures identified in rodents and macaques can be detected and measured in real human populations at scale.

Cellular Stress Links Damage to Organismal Aging

One of the more striking findings from the study involves laboratory-grown cells subjected to stress. When the researchers exposed cell cultures to prolonged culturing or ionizing radiation, hallmarks of the aging signature appeared. The same gene expression changes that accumulate gradually across decades in a living organism can be induced in days by cellular stress in a petri dish.

This finding, which Tyshkovskiy described as “linking cellular damage to tissue and organismal aging,” bridges two previously somewhat separate fields: the biology of age-related decline and the biology of DNA damage response. It suggests that the accumulation of cellular stressors, from radiation to metabolic byproducts to replication errors, drives the same molecular aging program that natural chronological aging activates. This has implications for why people who experience high cumulative cellular stress, whether from chronic inflammation, environmental toxins, or poor metabolic health, may age biologically faster than their birth certificates suggest.

What Calorie Restriction Reveals About the Clock

The responsiveness of the transcriptomic clocks to calorie restriction is among the most practically significant findings in the paper. Calorie restriction has been studied for decades as the most reproducible intervention for extending lifespan across multiple species. The mechanisms have been debated, but this study provides molecular clarity: calorie restriction modulates the same gene expression modules that the aging clocks measure.

Crucially, different interventions were found to affect biological age through distinct primary processes. A drug that targets inflammation-related modules may show up clearly in one set of transcriptomic clocks but not others. A metabolic intervention like calorie restriction may affect energy production modules most prominently. This modular resolution gives researchers a new level of precision when evaluating whether a longevity intervention is actually doing what it claims to do, and through which biological pathway.

This could eventually transform how clinical trials in longevity medicine are designed. Rather than waiting years to measure survival endpoints, researchers may be able to detect whether a drug is shifting the transcriptomic aging signal within months. This has enormous implications for the pace of drug development in geroscience.

The Cross-Species Confirmation Changes the Field

One reason prior aging research has translated imperfectly from animals to humans is that molecular findings in mouse models often fail to replicate in human tissue. The universal transcriptomic hallmarks study directly addresses this gap. By identifying gene expression patterns that hold across mice, rats, macaques, and humans simultaneously, the team established a cross-species validated foundation that prior single-species studies could not provide.

The inclusion of macaques is particularly important. Macaques are non-human primates, far closer to human biology than rodents. The fact that the same aging modules appear in macaque tissues as in mouse and human tissues suggests that these signatures are not artifacts of specific evolutionary pressures but are genuinely conserved features of mammalian biology. This substantially increases confidence that interventions validated in animal models against these molecular endpoints will translate to human benefit.

The tools developed in the study, including an interactive web platform and an R package for transcriptomic clock analysis, have been made available to the scientific community for non-commercial use. The authors were careful to note that the clocks are currently research tools, not clinical tests, and that further validation in prospective human studies will be required before they can guide patient care.

Where the Research Goes From Here

The Tyshkovskiy and Gladyshev team has filed a US patent application covering aspects of this work, a signal that clinical translation is actively being pursued. The broad scope of the finding, covering inflammation, mitochondrial function, extracellular matrix remodeling, and immune senescence as distinct, measurable aging modules, means that multiple therapeutic strategies could be evaluated using this framework.

Several avenues are already visible. Senolytic compounds, which clear CDKN1A-expressing senescent cells, could have their efficacy measured against the inflammation-linked transcriptomic clocks. Galectin-3 inhibitors, already under investigation for heart failure, could be evaluated for broader anti-aging effects using the LGALS3-associated modules. Metabolic interventions including calorie restriction mimetics, such as rapamycin and metformin, could be assessed in clinical trials using the energy production modules as molecular readouts. And emerging partial epigenetic reprogramming therapies, such as ER-100 from Life Biosciences, whose first human trial was cleared by the FDA in January 2026, could potentially use the transcriptomic clocks as biological age readouts to assess whether reprogramming is actually reversing the universal aging signature.

The study was funded by the National Institute on Aging, the Hevolution Foundation, the James Fickel and Michael Antonov Foundations, and multiple Japanese scientific agencies. The breadth of institutional backing reflects the growing recognition, within both government science funding and private longevity philanthropy, that molecular tools for measuring biological age are not a luxury. They are the prerequisite for the next generation of longevity medicine.

What This Means for You

The practical implications of this research will not arrive in a clinic next month. The transcriptomic clocks are research tools today, not diagnostic tests. But the biological framework they reveal has immediate implications for how you should think about the choices you make for your health.

The finding that cellular stress from radiation, prolonged damage, and poor metabolic control activates the same aging program as natural chronological aging reinforces what research in the longevity field has been building toward for years. The foundational practices that protect cellular health, reducing systemic inflammation, supporting mitochondrial function, maintaining metabolic stability through diet and exercise, and protecting against unnecessary stressors, are not soft wellness advice. They are interventions targeting the exact biological modules that this study identifies as the universal machinery of aging.

The four fundamentals of physical health, nutrition, movement, sleep, and stress regulation through breathwork, are levers on the very processes this Nature study mapped. Chronic inflammation, which poor diet and sedentary behavior amplify, maps directly to the inflammation modules in the transcriptomic aging clock. Mitochondrial dysfunction, which physical inactivity accelerates, maps to the energy production modules. Sleep disruption elevates inflammatory markers that correspond to the mortality-associated gene expression patterns the study identified.

Conversely, calorie restriction and exercise, two of the most reliably evidence-based longevity interventions, show up clearly in the transcriptomic signal as modulators of the universal aging program. This research provides the molecular confirmation for what robust clinical evidence has suggested for years: how you live every day is measurably changing how your cells age.

The universal aging code has now been mapped. The choices that slow or accelerate it are not mysteries. They are daily decisions about nutrition, movement, recovery, and the management of metabolic and inflammatory load. What this landmark study provides is the molecular vocabulary to understand why those decisions matter at the most fundamental level of biology.

Source: Tyshkovskiy A, et al. “Universal transcriptomic hallmarks of mammalian ageing and mortality.” Nature, 2026. DOI: 10.1038/s41586-026-10542-3. Mass General Brigham press release, May 27, 2026.

Free Daily Briefing

The Latest Longevity Science.
Delivered Every Morning.

Join researchers, physicians, and health professionals getting daily breakthroughs in AI-driven medicine, epigenetics, and longevity research.

Support the research that powers this editorial

Subscribe Free

No spam. Unsubscribe anytime. We respect your inbox.